ALS-associated mutations in the NLS of FUS disrupt binding to transportin-1, preventing its solubilizing effects on FUS and leading to FUS accumulation in stress granules (Hofweber et al., 2018). The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.